Kemoterápia okozta szenzoros neuropátiák jellegzetességei, diagnosztikája és kezelése

Ildikó Istenes, Zsolt Nagy, J. Demeter

Research output: Review article

1 Citation (Scopus)


Longer remissions and better overall survival rates can be achieved with the introduction of new, effective treatments and targeted therapies in the past 1-2 decades, however, the incidence of side effects is also increasing parallelly. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially debilitating side effect due to peripheral somatic or autonomic nerve dysfunction. CIPN becomes increasingly important, as it affects patients' quality of life, and it is very often a dose limiting factor with the potential for reduced treatment efficacy. The pathomechanism, diagnosis, prevention and treatment possibilities are described in this review with special attention to the different groups of drugs.

Original languageHungarian
Pages (from-to)165-175
Number of pages11
JournalMagyar Onkologia
Issue number2
Publication statusPublished - jún. 6 2016


ASJC Scopus subject areas

  • Oncology

Cite this